Capture
Capture specializes in developing innovative and agile solutions for times of crisis, focusing on radiation biodosimetry. Their flagship product, MiRAD™, is a high-throughput, microRNA biomarker-based biodosimetry assay designed to quickly and accurately assess radiation exposure from minimal blood samples. The company aims to provide rapid, minimally invasive, and reliable tools for emergency responders and medical professionals to triage and treat victims of radiological incidents.
Industries
Nr. of Employees
small (1-50)
Products
High-throughput miRNA-based PCR biodosimetry assay kit
A two-part kit for estimating absorbed ionizing radiation dose from a small blood sample: point-of-care collection and transport materials combined with central-lab reagents and primers for miRNA PCR analysis. Designed for minimal sample volume and rapid processing.
Capture
Capture translates workforce movements into structured company signals, providing early insights into organizational changes for public and private companies.
High-throughput miRNA-based PCR biodosimetry assay kit
A two-part kit for estimating absorbed ionizing radiation dose from a small blood sample: point-of-care collection and transport materials combined with central-lab reagents and primers for miRNA PCR analysis. Designed for minimal sample volume and rapid processing.
Capture
Capture translates workforce movements into structured company signals, providing early insights into organizational changes for public and private companies.
Services
Analysis of collected finger‑stick blood samples at a central molecular laboratory using a high-throughput miRNA PCR assay to estimate absorbed radiation dose and report results to clinical or emergency personnel.
Collaborative R&D and validation support for miRNA biomarker studies, assay optimization, and translational research informed by prior publications and conference presentations.
Management of patent-backed biomarker technology and licensing for deployment or commercialization of miRNA-based biodosimetry methods.
Analysis of collected finger‑stick blood samples at a central molecular laboratory using a high-throughput miRNA PCR assay to estimate absorbed radiation dose and report results to clinical or emergency personnel.
Collaborative R&D and validation support for miRNA biomarker studies, assay optimization, and translational research informed by prior publications and conference presentations.
Management of patent-backed biomarker technology and licensing for deployment or commercialization of miRNA-based biodosimetry methods.
Expertise Areas
- Radiation biodosimetry
- miRNA biomarker discovery and validation
- High-throughput molecular diagnostics
- Assay kit design and sample logistics
Key Technologies
- Real-time PCR (qPCR)
- miRNA-based biomarker assays
- Finger‑stick blood collection
- High-throughput assay kit architecture
News & Updates
Capture maintains an exclusive license to two patents (US # 9890428 and # 10407726) related to miRNA biomarkers for radiation biodosimetry.
Capture maintains an exclusive license to two patents (US # 9890428 and # 10407726) related to miRNA biomarkers for radiation biodosimetry.